Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Phase, Double Blind, Placebo-Controlled, Randomized, Crossover Study of the Safety and Efficacy of Intra-Oral NH004 Films for the Short-Term Relief of Sialorrhea Symptoms in Parkinson's Disease Patients

NCT00761137 is registered in ClinicalTrials.gov with NeuroHealing Pharmaceuticals Inc. as lead sponsor.

NCT NCT00761137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00761137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Phase, Double Blind, Placebo-Controlled, Randomized, Crossover Study of the Safety and Efficacy of Intra-Oral NH004 Films for the Short-Term Relief of Sialorrhea Symptoms in Parkinson's Disease Patients
Lead sponsor
NeuroHealing Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
June 30, 2010
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sialorrhea secondary to parkinson's disease